Summary: BP’s U.S. ADR set a fresh 52‑week high on Friday as the company pressed ahead with daily share repurchases and crude prices stabilized into the weekend. Broker commentary during 6–7 November stayed constructive, while London filings confirmed chunky buybacks across both days. Reuters+4MarketWatch+4Investegate+4
BP share price today (7 Nov 2025)
- ADR close (NYSE: BP):$36.58, up ~2.1% on the day, marking a new 52‑week high and a fourth straight daily gain. MarketWatch also noted sub‑average volume, but enough momentum to eclipse the prior high set earlier this week. MarketWatch
What changed on 6–7 November
1) Daily buybacks confirmed in London
BP disclosed two consecutive “Transaction in Own Shares” notices:
- 7 Nov: Repurchased 1,546,843 ordinary shares, with venue‑level volume‑weighted average prices around 458.6p; the day’s ranges topped out near 462.35p. Shares are intended for treasury. Investegate
- 6 Nov: Repurchased 1,560,364 ordinary shares, VWAPs around 457.1p–457.5p across LSE and Cboe venues; intraday prices ranged roughly 454.05p–460.05p. Also headed to treasury. Investegate
These prints show the new $750m Q4‑ahead buyback announced earlier in the week is now fully in motion, with steady daily execution. Shares Magazine
2) Oil price backdrop steadied
Crude trended firmer into Friday after mid‑week softness: Brent hovered ~$63–64/bbl on 6–7 Nov, with headlines citing oversupply concerns but a modest Friday rebound heading into the weekend. Saudi Arabia’s move to cut December OSPs and the latest OPEC+ supply signals also framed sentiment. For integrated majors like BP, even small stabilizations in crude can support short‑term equity moves. Reuters+2Reuters+2
3) London market color
On 6 Nov, the FTSE 100 extended its upswing helped by energy shares; BP gained ~1.6–1.8% intraday alongside firmer oil. Reuters
4) Fresh broker chatter
During the 6–7 Nov window, RBC reiterated “Sector Perform” on BP with a 500p price target, reflecting watchful optimism after the Q3 beat and buyback restart. (Aggregator summary.) MarketBeat
Context for the week: Q3 results and payout cadence
BP’s Q3 2025 print earlier this week came in better than feared, with underlying RC profit around $2.2bn, operating cash flow ~$7.8bn, and a new $750m buyback targeted for completion before Q4 results. The dividend remains 8.32c per share (quarterly). These updates set the tone for the later‑week share‑price strength and the daily buyback notices on 6–7 Nov. bp.com+1
Key takeaways for investors today
- Momentum: The ADR closed at a 52‑week high on 7 Nov, extending a multi‑day rally. MarketWatch
- Direct support from buybacks: Two straight days of 1.55–1.56m shares retired into treasury underscore active capital returns during the current program. Investegate+1
- Macro still matters: Oil’s late‑week stabilization helped sentiment, but headlines continue to flag oversupply risk—keep an eye on OPEC+ signals and weekly U.S. inventory data. Reuters+1
- Street stance:RBC 500p (Sector Perform) adds to the picture of tempered but constructive broker views following the Q3 update. MarketBeat
Timeline: 6–7 November (all times local market)
- 6 Nov (London): BP files Transaction in Own Shares for 1,560,364 shares repurchased across LSE/Cboe; prices centered near 457p VWAP. Investegate
- 6 Nov (Europe afternoon): Oil edges up after a mid‑week dip; sentiment improves into the close. FTSE 100 extends gains; BP advances with energy peers. Reuters+1
- 7 Nov (London): Another BP buyback filing for 1,546,843 shares; ranges near 456–462p. Investegate
- 7 Nov (U.S. close):BP ADR finishes at $36.58, a new 52‑week high; rally stretches to four sessions. MarketWatch
What to watch next
- Daily RNS buyback prints: Expect continued disclosures while the $750m program runs toward completion ahead of the Q4 release window. Shares Magazine
- Oil tape: Direction of Brent after the latest OPEC+/OSP headlines will remain a near‑term swing factor for BP’s beta. Reuters+1
Disclosure & methodology: This article aggregates regulatory filings (RNS/Investegate), major wire services and market‑data sources dated 6–7 November 2025. Figures are based on official releases and widely used financial data providers; this is journalistic analysis, not investment advice. MarketWatch+4Investegate+4Investegate+4
